Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label

Details for Australian Patent Application No. 2008258859 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Lenz, Helmut; Hasmann, Max; Scheuer, Werner

Agent Davies Collison Cave

Pub. Number AU-A-2008258859

PCT Pub. Number WO2008/148546

Priority 07011087.9 06.06.07 EP

Filing date 4 June 2008

Wipo publication date 11 December 2008

International Classifications

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

5 November 2009 PCT application entered the National Phase

  PCT publication WO2008/148546 Priority application(s): WO2008/148546

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258863-Multilayered material sheet for use in soft ballistics

2008258857-A device, charging unit and method of filling a borehole with an explosive material